Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | NEPHROPLUS Nephrocare Health Services Limited Pharma · Small | MAITREYA Maitreya Medicare Ltd. Pharma · SME | SANGANI Sangani Hospitals Ltd. Pharma · SME | QMSMEDI QMS Medical Allied Services Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 38 | 16 | 37 | 35 |
| Verdict | WATCHLIST | OVERVALUED | WATCHLIST | WATCHLIST |
| Style | WATCHLIST | OVERVALUED | WATCHLIST | WATCHLIST |
| Piotroski | 8/9 | 6/9 | 7/9 | 8/9 |
| Valuation | 0/30 | 4/30 | 13/30 | 16/30 |
| Growth | 20/25 | 7/25 | 12/25 | 14/25 |
| Quality | 3/20 | 0/20 | 3/20 | 0/20 |
| Balance Sheet | 9/15 | 7/15 | 10/15 | 7/15 |
| Cash Flow | 2/10 | 2/10 | 2/10 | 1/10 |
| Price | ₹709.25 | ₹154 | ₹45 | ₹93.35 |
| P/E | 92.70 | — | 20.70 | 17.80 |
| P/B | 6.39 | 3.60 | 1.51 | 1.73 |
| ROE | 9.06% | -8.86% | 7.76% | 10.40% |
| ROCE | 15.50% | -2.18% | 17.40% | 13.20% |
| Debt / Equity | 0.07 | 0.80 | 0.05 | 0.65 |
| FCF Yield | — | — | — | — |
| Dividend Y | — | — | — | 0.54% |
| Altman Z | 8.50 | 2.73 | 2.14 | 2.95 |
| Promoter % | 63.85% | 73.11% | 74.09% | 68.11% |
| Mkt Cap (₹Cr) | 7124.00 | 104.00 | 62.00 | 181.00 |
| Graham # | ₹138.31 | — | ₹38.14 | ₹79.72 |
| Fair PE | 42.0 | 30.3 | 30.3 | 42.0 |
| MoS % | -120.5% | — | +31.5% | +57.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startNEPHROPLUS158
MAITREYA118
SANGANI100
QMSMEDI63